# Japanese Phase 1 Multiple Ascending Dose (MAD) Study

> **NCT01396252** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 57 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** BMS-820836
- **DRUG:** BMS-820836
- **DRUG:** BMS-820836
- **DRUG:** Placebo matching BMS-820836
- **DRUG:** BMS-820836

## Key facts

- **NCT ID:** NCT01396252
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2013-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01396252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01396252, "Japanese Phase 1 Multiple Ascending Dose (MAD) Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01396252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*